51黑料吃瓜在线观看,51黑料官网|51黑料捷克街头搭讪_51黑料入口最新视频

人工肝的研究已有半世紀(jì)之久，自人工肝概念提出以來，人工肝的理念、技術(shù)、設(shè)備、臨床應(yīng)用等不斷更新，目前已經(jīng)基本形成了非生物型、生物型和混合型人工肝的三大類型。本文對其發(fā)展歷史及現(xiàn)狀進(jìn)行了概述。

［1］Kiley JE，Welch HF，Pender JC，et al. Removal of blood ammonia by hemodialysis ［J］. Pro Soc Exp Biol Med，1996，91:489-490.
［2］Norman JC，Saravis CA，Brown M，et al. Immunochemical observations in clinical heterologous(xenogeneic）liver perfusion ［J］. Surgery，1996，60:179-190.
［3］Agishi T，Nakagawa Y，Teraoka S，et al. Plasma exchange as rescure strategy for hpatic failure ［J］. ASAIO Trans，1994，40：77.
［4］中華傳染病與寄生蟲病學(xué)會人工肝學(xué)組.人工肝支持系統(tǒng)治療的操作指南［J］.中華肝臟病雜志，2002,10(5)：329-333.
Artificial liver group，Chinese association of infectious and parasitic diseases. Operating guide for artificial liver support system［J］. Chinese Journal of Hepatology，2002,10(5)：329-333.
［5］Onodera K，Sakata H，Yonekawa M，et al. Artificial liversupport at present and in the future［J］. J Artif Organs,2006，9:17-28.
［6］劉拉羊,趙良,孫曉娟,等.分子吸附循環(huán)系統(tǒng)(MARS)人工肝治療對重型肝炎單核細(xì)胞免疫功能的影響［J］.中國急救醫(yī)學(xué),2005,25(12):869-872.
Liu Layang，Zhao Liang，Sun Xiaojuan，et al. Effects of molecular adsorbent recirculating system(MARS）［J］.China Academic Journal Electronic Pulishing House，2005,25(12):869-872.
［7］李蘭娟. 人工肝臨床應(yīng)用若干進(jìn)展［J］. 中華肝臟病雜志，2005,13(11):844-845.
Li Lanjuan. Progress in clinical application of artificial liver support systems［J］. Chinese Journal of Hepatology，2005,13(11):844-845.
［8］Laleman W，Wilmer A，Evenepoel P，et al. Review article：non-biological liver support in liver failure ［J］. AlimentPharmocol Ther，2006，23:351-363.
［9］Rifai K，Ernst T，Kretschmer U，et al. Removal selectivityof Prometheus：A new extracorporeal liver support device ［J］. World J Gastroenterol，2006，12(6):940-944.
［10］葉衛(wèi)江，李蘭娟，俞海燕，等.血漿置換聯(lián)合血液濾過治療慢性乙型重型肝炎的臨床研究［J］.中華肝臟病雜志，2005，13(5):370-373.
Ye Weijiang，Li Lanjuan，Yu Haiyan，et al. Clinical research of plasma exchange with continuous veno-venous hemofiltration in treating mid-and late-stage chronic severe viral hepatitis B patients［J］. Chinese Journal of Hepatology，2005，13(5):370-373.
［11］He NH，Wang YJ，Wang ZW，et al. Effects of hemoperfusion adsorption and/or plasma exchange in treatment of severe viral hepatitis：A comparative study ［J］.World J Gastroenterol，2004，10(8):1218-1221.
［12］蔣茵，農(nóng)村立，李巧于,等.人工肝血漿置換并發(fā)癥觀察與處理［J］. 中國醫(yī)藥科學(xué),2011，1(20)：174-175.
［13］Mazariegos GV，Patzer JF 2nd，Lopez RC，et al. First clinical use of anovel bioartificial liver support system(BLSS）［J］. Am J Transplant，2002,2(3)：260-266.
［14］Meng Q，Zhang GL，Wu DQ. Hepatocyte culture in bioartificial liverswith different membrane characteristics［J］. Biotechnol Let，2004,26（18)：1407-1412.
［15］Leclerc E，Sakai Y，F(xiàn)ujii T. Microfluidic PDMS（Polydimethylsiloxane）bioreactor for large-scale culture of hepatocytes［J］. Biotechnol Prog，2004，20(3)：750-755.
［16］Kobayashi N，Okitsu T，Nakaji S，et al. Hybrid bioartificial liver：establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use［J］. J Artif Organs，2003,6(4)：236-244.
［17］Selen PO. Preparation of isolated rat liver cells［J］. Methed Cell Biol，1976,13:20-83
［18］Selen PO. Isolation of hepatocytes by collagenase perfusion［J］. Metheds Tosicol，1993,1:231-234.
［19］Nieuwoudt MJ，Moolman SF，van Wyk KJ，et al. Hepatocyte function in a radial-flow bioreactor using a perfluorocarbon oxygen carrier［J］. Artif Organs，2005，29(11)：915-918.